KS

Kanika Sharma

Active Director Director DIN 08435145
DIN 08435145 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Kanika Sharma

Data last updated:

Kanika Sharma is a Director at Mkv Pharma Private Limited (since 2019). The company operates in Pharma. Mkv Pharma Private Limited reported revenue of ₹18.8 Lakh (FY 2025).

DIN 08435145
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 2019
Oldest Company Age 7 yrs
Largest company Mkv Pharma Private Limited · ₹18.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mkv Pharma Private Limited U51909DL2019PTC349190
Director26 Apr 20192019₹18.8 Lakh (FY 2025)Active

Board colleagues of Kanika Sharma

NameDINCompanyDesignation
Vineet Kumar06439105Mkv Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mkv Pharma Private Limited
Premium access

Shareholding and investment profile for Kanika Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanika Sharma

Kanika Sharma currently holds 1 directorship: Mkv Pharma Private Limited (Director, since 26 Apr 2019, revenue ₹18.8 Lakh (FY 2025)).

Kanika Sharma was first appointed on 26 Apr 2019 as Director at Mkv Pharma Private Limited.

The current boards of Kanika Sharma's companies include Vineet Kumar (Mkv Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available